Notice of Effectiveness (effect)
July 12 2022 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | July 11,
2022 |
---|
Form: | S-3 |
---|
CIK: | 0001811764 |
---|
Company Name: | POINT Biopharma Global Inc. |
---|
File Number: | 333-265981 |
---|
Therapeutics Acquisition (NASDAQ:RACA)
Historical Stock Chart
From May 2024 to Jun 2024
Therapeutics Acquisition (NASDAQ:RACA)
Historical Stock Chart
From Jun 2023 to Jun 2024